A Correlative Study of Lung Cancer Treatment Response
Description: 

This study has been designed to identify potential chemicals in blood that may identify patients at risk for lung cancer recurrence.

Study Number: 

I 188810

Phase: 
Pilot
Principal Investigator: 

To inquire about participating in these studies, call 1-877-ASK-RPCI (1-877-275-7724) or e-mail askrpci@roswellpark.org.